This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.Need a new registration confirmation email? Click here

The mainly mall-based department store chain was upbeat about the current quarter, guiding earnings within range of the Wall Street consensus.

Net income was $1 million, which because of preferred dividends translated into a loss of 2 cents a share in the second quarter. The company had break-even results, or a loss of 2 cents a share, a year ago. Results in both quarters included losses associated with the Eckerd division.

Penney said earnings from continuing operations were 23 cents a share in the three months ended July 31, compared to a loss of 3 cents a share in the year-earlier period. Total sales were up 5.8% at $3.86 billion, with same-store department store sales up 7.1%. Same-store Internet and catalog sales dropped 1.6%, however.

During the quarter, Plano, Texas-based Penney completed the $4.5 billion sale of its Eckerd drugstore chain to both
CVS(CVS - Get Report) and
Jean Coutu Group, operator of the Brooks Pharmacy chain in the Northeast. The operating loss in the just-completed quarter related to the Eckerd sale was $71 million, net of taxes, the company said.

Tuesday's results come as no shock, as the company upped its second-quarter earnings expectation to 22 cents a share on Aug. 2, well ahead of analysts' consensus estimate at the time. It also announced a $3 billion stock buyback program to be completed over the next year and a plan to retire $2.3 billion in debt. The moves are expected to improve the company's balance sheet by $8 billion.

The company said Tuesday that operating profit in the second quarter jumped to $156 million, from $53 million in the year-ago quarter.

Product Features:

To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.